Top compounds associated with response to CTD-2021K4.1


Feature Type Standardized
Nominal ANOVA
mRNA austocystin d CTRPv2 pan-cancer AAC 0.091 0.02
mRNA Teniposide CTRPv2 pan-cancer AAC 0.094 0.02
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.02
mRNA clofarabine CTRPv2 pan-cancer AAC 0.071 0.02
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.11 0.02
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.081 0.02
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.085 0.02
mRNA YM-155 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC -0.097 0.02
mRNA Panobinostat CTRPv2 pan-cancer AAC 0.078 0.02
Download CSV